Corbus Pharmaceuticals Holdings, Inc. Marketable Securities, Unrealized Gain (Loss)
Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported Marketable Securities, Unrealized Gain (Loss) of $54.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:MarketableSecuritiesUnrealizedGainLoss · last filed 2026-08-06
- Corbus Pharmaceuticals Holdings, Inc. marketable securities, unrealized gain (loss) for the quarter ending 2026-06-30 was $54.00K.
- Corbus Pharmaceuticals Holdings, Inc. marketable securities, unrealized gain (loss) for the quarter ending 2026-03-31 was -$108.00K.
- Corbus Pharmaceuticals Holdings, Inc. marketable securities, unrealized gain (loss) for the quarter ending 2025-12-31 was -$50.00K.
- Corbus Pharmaceuticals Holdings, Inc. marketable securities, unrealized gain (loss) for the quarter ending 2025-09-30 was $36.00K, a 93.95% decline year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. marketable securities, unrealized gain (loss) for fiscal 2025 was -$88.00K, a 344.44% decline from fiscal 2024.
- Corbus Pharmaceuticals Holdings, Inc. marketable securities, unrealized gain (loss) for fiscal 2024 was $36.00K, a 71.20% decline from fiscal 2023.
- Corbus Pharmaceuticals Holdings, Inc. marketable securities, unrealized gain (loss) for fiscal 2023 was $125.00K.
- Corbus Pharmaceuticals Holdings, Inc. marketable securities, unrealized gain (loss) for fiscal 2022 was -$63.65K.
| Period end | Marketable Securities, Unrealized Gain (Loss) 3 month | Marketable Securities, Unrealized Gain (Loss) 3 month as first filed | Marketable Securities, Unrealized Gain (Loss) 6 month | Marketable Securities, Unrealized Gain (Loss) 6 month as first filed | Marketable Securities, Unrealized Gain (Loss) 9 month | Marketable Securities, Unrealized Gain (Loss) 9 month as first filed | Marketable Securities, Unrealized Gain (Loss) 12 month | Marketable Securities, Unrealized Gain (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $54.00K 10-Q · filed 2026-08-06 | -$54.00K 10-Q · filed 2026-08-06 | -$104.00K derived: sum of 3 quarters · filed 2026-08-06 | -$68.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | -$108.00K 10-Q · filed 2026-05-12 | -$158.00K derived: sum of 2 quarters · filed 2026-05-12 | -$122.00K derived: sum of 3 quarters · filed 2026-05-12 | -$138.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | -$50.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$14.00K derived: sum of 2 quarters · filed 2026-03-09 | -$30.00K derived: sum of 3 quarters · filed 2026-08-06 | -$88.00K 10-K · filed 2026-03-09 | ||||
| 2025-09-30 | $36.00K 10-Q · filed 2025-11-12 | $20.00K derived: sum of 2 quarters · filed 2026-08-06 | -$38.00K 10-Q · filed 2025-11-12 | -$210.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | -$16.00K 10-Q · filed 2026-08-06 | -$74.00K 10-Q · filed 2026-08-06 | -$246.00K derived: sum of 3 quarters · filed 2026-08-06 | $349.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | -$58.00K 10-Q · filed 2026-05-12 | -$230.00K derived: sum of 2 quarters · filed 2026-05-12 | $365.00K derived: sum of 3 quarters · filed 2026-05-12 | $306.00K derived: sum of 4 quarters · filed 2026-05-12 | ||||
| 2024-12-31 | -$172.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $423.00K derived: sum of 2 quarters · filed 2026-03-09 | $364.00K derived: sum of 3 quarters · filed 2026-03-09 | $36.00K 10-K · filed 2026-03-09 | ||||
| 2024-09-30 | $595.00K 10-Q · filed 2025-11-12 | $536.00K derived: sum of 2 quarters · filed 2025-11-12 | $208.00K 10-Q · filed 2025-11-12 | $214.00K derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | -$59.00K 10-Q · filed 2025-08-05 | -$387.00K 10-Q · filed 2025-08-05 | -$381.00K derived: sum of 3 quarters · filed 2025-08-05 | -$365.00K derived: sum of 4 quarters · filed 2025-08-05 | ||||
| 2024-03-31 | -$328.00K 10-Q · filed 2025-05-06 | -$326.95K 10-Q · filed 2024-05-07 | -$322.00K derived: sum of 2 quarters · filed 2025-05-06 | -$306.00K derived: sum of 3 quarters · filed 2025-05-06 | -$261.00K derived: sum of 4 quarters · filed 2025-05-06 | |||
| 2023-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $22.00K derived: sum of 2 quarters · filed 2025-03-11 | $67.00K derived: sum of 3 quarters · filed 2025-03-11 | $125.00K 10-K · filed 2025-03-11 | $124.54K 10-K · filed 2024-03-12 | |||
| 2023-09-30 | $16.00K 10-Q · filed 2024-11-07 | $15.75K 10-Q · filed 2023-11-07 | $61.00K derived: sum of 2 quarters · filed 2024-11-07 | $119.00K 10-Q · filed 2024-11-07 | $118.06K 10-Q · filed 2023-11-07 | $199.41K derived: sum of 4 quarters · filed 2024-11-07 | ||
| 2023-06-30 | $45.00K 10-Q · filed 2024-08-06 | $44.68K 10-Q · filed 2023-08-08 | $103.00K 10-Q · filed 2024-08-06 | $102.30K 10-Q · filed 2023-08-08 | $183.41K derived: sum of 3 quarters · filed 2024-08-06 | $95.85K derived: sum of 4 quarters · filed 2024-08-06 | ||
| 2023-03-31 | $57.62K 10-Q · filed 2024-05-07 | $138.41K derived: sum of 2 quarters · filed 2024-05-07 | $50.85K derived: sum of 3 quarters · filed 2024-05-07 | $101.22K derived: sum of 4 quarters · filed 2024-05-07 | ||||
| 2022-12-31 | $80.78K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | -$6.77K derived: sum of 2 quarters · filed 2024-03-12 | $43.60K derived: sum of 3 quarters · filed 2024-03-12 | -$63.65K 10-K · filed 2024-03-12 | ||||
| 2022-09-30 | -$87.55K 10-Q · filed 2023-11-07 | -$37.18K derived: sum of 2 quarters · filed 2023-11-07 | -$144.43K 10-Q · filed 2023-11-07 | -$197.91K derived: sum of 4 quarters · filed 2023-11-07 | ||||
| 2022-06-30 | $50.37K 10-Q · filed 2023-08-08 | -$56.88K 10-Q · filed 2023-08-08 | -$110.35K derived: sum of 3 quarters · filed 2023-08-08 | -$113.87K derived: sum of 4 quarters · filed 2023-08-08 | ||||
| 2022-03-31 | -$107.25K 10-Q · filed 2023-05-09 | -$160.73K derived: sum of 2 quarters · filed 2023-05-09 | -$164.24K derived: sum of 3 quarters · filed 2023-05-09 | -$140.93K derived: sum of 4 quarters · filed 2023-05-09 | ||||
| 2021-12-31 | -$53.48K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | -$56.99K derived: sum of 2 quarters · filed 2023-03-07 | -$33.68K derived: sum of 3 quarters · filed 2023-03-07 | -$62.45K 10-K · filed 2023-03-07 | ||||
| 2021-09-30 | -$3.51K 10-Q · filed 2022-11-08 | $19.80K derived: sum of 2 quarters · filed 2022-11-08 | -$8.97K 10-Q · filed 2022-11-08 | |||||
| 2021-06-30 | $23.31K 10-Q · filed 2022-08-09 | -$5.45K 10-Q · filed 2022-08-09 | ||||||
| 2021-03-31 | -$28.77K 10-Q · filed 2022-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |